Atlas Trials

Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm)

Clinical trial NCT03737565 · COMPLETED

Trial details

NCT number
NCT03737565
Sponsor
Fundación EPIC
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Artery Disease
Start date
2019-02-17
Primary completion
2025-01-02
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.